Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 40 out of 100. Getting a diagnosis

Topic: Amyloid, tau and blood-test diagnosis

score 0.8323, although only the AUC was statistically significantly different) and other AI-based models. Several of the AI-based models, including convolutional neural networks, also outperformed the CCW algorithm. These findings highlight the potential of AI-based text-classification methods to optimize the automated identification of patients with ADRD using rich EHR data. However, the success of this approach depends on the quality of clinical notes, and more work is needed to refine and validate these methods across more diverse data sets. Highlights: The current e-phenotype for patients with Alzheimer's disease and related dementias (ADRD) in electronic health records has suboptimal diagnostic accuracy.The study used artificial intelligence (AI)-based text classification methods to improve the detection of patients with ADRD.AI-based models, including convolutional neural networks, outperformed the Chronic Conditions Warehouse algorithm.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Knox, S., Aghamoosa, S., Heider, P. M., Cutty, M. E., Wright, A. W. E., Scherbakov, D., et al. (2025). AI approaches for phenotyping Alzheimer's disease and related dementias using electronic health records. Alzheimer s & Dementia Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.70089

Vancouver

Knox S, Aghamoosa S, Heider PM, Cutty ME, Wright AWE, Scherbakov D, et al. AI approaches for phenotyping Alzheimer's disease and related dementias using electronic health records. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2025. doi:10.1002/trc2.70089. PMID: 40291122.

BibTeX

@article{knox2025-40291122,
  author  = {Knox, Sara and Aghamoosa, Stephanie and Heider, Paul M. and Cutty, Maxwell E. and Wright, Andrew W. E. and Scherbakov, Dmitry and Hood, Gavin and Nolin, Sara A. and others},
  title   = {{AI approaches for phenotyping Alzheimer's disease and related dementias using electronic health records}},
  journal = {Alzheimer s \& Dementia Translational Research \& Clinical Interventions},
  year    = {2025},
  doi     = {10.1002/trc2.70089},
  pmid    = {40291122},
  url     = {https://doi.org/10.1002/trc2.70089}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

Artificial intelligence-based text classification methods outperformed a standard algorithm for identifying patients with Alzheimer's disease and related dementias from electronic health records. This is about improving automated identification and does not address treating, curing, or preventing the disease.

Study details

How this study scored 40/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 3 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 40 of 100.40 of 100 points earned60 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia Translational Research & Clinical Interventions)
Journal's citation record 1 / 4 Alzheimer s & Dementia Translational Research & Clinical Interventions: journal h-index 84 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 3 / 4 1,000 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.7 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.9× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Jihad S. Obeid: h-index 32 (OpenAlex, whole career)
Institution's track record 1 / 3 Medical University of South Carolina: institution h-index 715 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40291122)
Free to read 2 / 2 Free to read
Total 40 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Getting a diagnosis

Also in Getting a diagnosis

141 studies in the library are filed under Getting a diagnosis with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Getting a diagnosis hub.

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →